Bank Of America, Morgan Stanley, ASML, Omeros, Progressive: Stocks Making The Biggest Moves Today

Bank of America shares surged 4% in Wednesday’s midday session after the lender’s third-quarter results beat Wall Street expectations.

U.S. equities surged in Wednesday’s midday trade after stronger-than-expected earnings of big banks buoyed investor sentiment, overshadowing trade tensions following the flare-up with China.

The SPDR S&P 500 ETF (SPY), which mirrors the S&P 500 index, was up 0.33% at the time of writing, while the Invesco QQQ Trust (QQQ), which mirrors the Nasdaq 100 index, gained 0.67%. The SPDR Dow Jones Industrial Average ETF Trust (DIA), which tracks the Dow Jones Industrial Average, rose 0.12%.

Here are the top stocks making the biggest moves in Wednesday’s midday trade:

Bank of America Corp. (BAC)

Bank of America shares surged 4% in Wednesday’s midday session after the lender’s third quarter (Q3) results beat Wall Street expectations. Bank of America reported EPS of $1.06 on revenue of $28.24 billion, while analysts expected an EPS of $0.95 on revenue of $27.5 billion, according to Stocktwits data.

BAC stock is up 19% year-to-date.

Morgan Stanley (MS)

Morgan Stanley shares gained over 5% in Wednesday’s midday trade after the lender’s Q3 results beat Wall Street expectations. Morgan Stanley reported EPS of $2.8 on revenue of $18.22 billion, while analysts expected an EPS of $2.1 on revenue of $16.69 billion, according to Stocktwits data.

MS stock is up 30% year-to-date.

ASML Holding NV (ASML)

ASML shares were up more than 3% in Wednesday’s midday trade after the semiconductor equipment manufacturer’s third-quarter (Q3) results. ASML reported earnings per share (EPS) of $6.37 on revenue of $8.71 billion, while analysts expected an EPS of $6.36 on revenue of $9.02 billion, according to Stocktwits data.

ASML stock is up 45% year-to-date.

Omeros Corp. (OMER)

Omeros shares soared 149% in Wednesday’s midday trade after Dutch pharmaceutical giant Novo Nordisk AS (NVO) said that it has entered into a definitive asset purchase and license agreement for Omeros’ drug candidate Zaltenibart.

OMER stock is up 3% year-to-date.

Progressive Corp. (PGR)

Progressive shares were down by more than 7% in Wednesday’s midday session after the company’s Q3 results came in below expectations. Progressive reported EPS of $3.95 on revenue of $21.38 billion, while analysts expected an EPS of $5.04 on revenue of $21.81 billion, according to Stocktwits data.

PGR stock is down 7% year-to-date.

For updates and corrections, email newsroom[at]stocktwits[dot]com.<